Reference: TIRZDPEN10 Tirzepatide Disposable Pen Tirzepatide was originally developed to treat Type-2 diabetes but has since become a leading anti-obesity medication
By using established isovolumetric isolated perfused rat hearts, we observed that activation of GLP-1 receptor with GLP-1 significantly mitigated myocardial injury as indicated by an improvement in recovery of developed pressure and end-diastolic pressure as well as rate pressure products [26]
Dietary modifications form the cornerstone of managing Wegovy-related digestive symptoms: Increase fibre intake gradually through fruits, vegetables, whole grains, and legumes to promote regular, soft bowel movements Maintain adequate hydration (approximately 68 glasses of fluid daily) to prevent constipation and reduce dehydration risk Eat smaller, more frequent meals rather than large portions to reduce nausea and bloating Avoid high-fat, fried, or heavily processed foods that may exacerbate gastrointestinal discomfort Limit carbonated beverages that can increase bloating For constipation specifically , which poses the greatest theoretical risk for haemorrhoid development: Consider osmotic laxatives (e.g., macrogol) as first-line treatment, especially if bloating is present Bulk-forming laxatives (e.g., ispaghula husk) may be helpful but use cautiously if experiencing bloating Establish a regular toilet routine without prolonged sitting or straining Increase physical activity , which promotes intestinal motility Avoid constipating medications where possible (e.g., codeine, some antihistamines) Some patients find that adjusting medication timing helps manage symptoms, though this is not specified in the SmPC
Tirzepatide has shown even greater efficacy, with some patients losing up to 20% of their body weight
